Societe de Promotion Pharmaceutique du Maghreb Balance Sheet Health
Financial Health criteria checks 6/6
Societe de Promotion Pharmaceutique du Maghreb has a total shareholder equity of MAD452.6M and total debt of MAD104.5M, which brings its debt-to-equity ratio to 23.1%. Its total assets and total liabilities are MAD883.5M and MAD430.9M respectively. Societe de Promotion Pharmaceutique du Maghreb's EBIT is MAD115.5M making its interest coverage ratio 57.5. It has cash and short-term investments of MAD133.5M.
Key information
23.1%
Debt to equity ratio
د.م104.50m
Debt
Interest coverage ratio | 57.5x |
Cash | د.م133.47m |
Equity | د.م452.60m |
Total liabilities | د.م430.93m |
Total assets | د.م883.54m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PRO's short term assets (MAD618.1M) exceed its short term liabilities (MAD355.1M).
Long Term Liabilities: PRO's short term assets (MAD618.1M) exceed its long term liabilities (MAD75.8M).
Debt to Equity History and Analysis
Debt Level: PRO has more cash than its total debt.
Reducing Debt: PRO's debt to equity ratio has reduced from 41.1% to 23.1% over the past 5 years.
Debt Coverage: PRO's debt is well covered by operating cash flow (190.6%).
Interest Coverage: PRO's interest payments on its debt are well covered by EBIT (57.5x coverage).